Table 1.
Correlation between Bmi-1 expression and clinical-pathologic features of the patient with bladder cancer
| Bmi-1 expression | P | |||
|---|---|---|---|---|
| Characteristics | n | Low | High | |
| Gender | ||||
| Male | 115 | 58 (50.4%) | 57 (49.6%) | 0.226 |
| Female | 22 | 8 (36.4%) | 14 (63.6%) | |
| Age | ||||
| ≤ 50 | 49 | 26 (53.1%) | 23 (46.9%) | 0.393 |
| > 50 | 88 | 40 (45.5%) | 48 (54.5%) | |
| Tumor number | ||||
| ≤ 3 | 91 | 47 (51.6%) | 44 (48.4%) | 0.255 |
| > 3 | 46 | 19 (41.3%) | 27 (58.7%) | |
| Histological grade | ||||
| G1 | 34 | 27 (79.4%) | 7 (20.6%) | 0.001 |
| G2 | 70 | 32 (45.7%) | 38 (54.3%) | |
| G3 | 33 | 7 (21.2%) | 26 (78.8%) | |
| Clinical stage | ||||
| Ta, T1 | 83 | 56 (67.5%) | 27 (32.5%) | 0.001 |
| T2, T3, T4 | 54 | 10 (18.5%) | 44 (81.5%) | |
| Superficial cancer | ||||
| No recurrence | 51 | 44 (86.3%) | 7 (13.7%) | 0.001 |
| Recurrence | 32 | 12 (37.5%) | 20 (62.5%) | |